Study tracks SARS-CoV-2 exposure in pets from infected homes

A newly published study in Frontiers in Veterinary Science takes another look at the human-pet interface in COVID-19-positive households, using samples collected in Madrid during the strict early-pandemic lockdown. The paper, published July 20, 2026, reports that nearly three in 10 cats and dogs in the cohort had SARS-CoV-2 antibodies, despite all tested animals being RT-qPCR-negative at sampling, suggesting prior exposure rather than active infection at the time of collection. (frontiersin.org)

The work sits in a long-running One Health conversation about reverse zoonosis, especially in homes where infected people and pets share close space for prolonged periods. According to the paper, the cohort included 87 pets, 18 cats and 69 dogs, recruited through veterinary clinics and hospitals in Madrid from households with at least one confirmed human COVID-19 case. Sampling occurred between June 2020 and March 2021, typically one to three weeks after the person’s diagnosis, a delay that likely reduced the chances of catching active viral shedding in the animals. (frontiersin.org)

The key findings were straightforward but useful. Specific antibodies were detected in 27.8% of cats and 30.4% of dogs, with comparable canine seroprevalence in households of healthcare and non-healthcare workers. The authors did not find significant associations between the pets’ SARS-CoV-2 serostatus and the individual risk factors they analyzed. They did, however, identify moderate associations between canine symptoms and factors such as vaccination status, contact with people or other animals, and diet, plus a moderate association in cats between respiratory signs and having a healthcare worker in the household. (frontiersin.org)

What makes the paper more distinctive is its immunology angle. In dogs, the authors found a strong association between SARS-CoV-2 antibodies and antibodies against common canine pathogens, specifically canine adenovirus, canine parvovirus, and canine distemper virus, with Cramer’s V values above 0.6. That does not show that routine vaccination or prior pathogen exposure protects against SARS-CoV-2, and the paper does not make that causal claim. Instead, it raises a question worth testing in larger studies: whether a pet’s existing immune background may shape how it responds to spillover exposure in the household. (frontiersin.org)

The study’s limitations matter. The feline sample was small, the design was exploratory, and the lockdown-era setting created an unusual exposure environment that may not reflect later pandemic conditions or current household behavior. The authors themselves describe the findings as preliminary and hypothesis-generating, particularly for the feline cohort and the broader question of multifactorial risk at the human-animal interface. (frontiersin.org)

Outside this paper, the broader field has landed on a fairly consistent interpretation. CDC says pets can become infected, mostly after close contact with people with COVID-19, but the risk of animals spreading the virus to people is low. USDA APHIS and WOAH make similar points, emphasizing surveillance and risk management while noting that companion animals are not considered to be playing a meaningful epidemiological role in sustaining human transmission. U.S. veterinary guidance has also remained cautious on testing: AVMA and partner agencies have said routine testing of animals for SARS-CoV-2 is not recommended, and decisions should be made collaboratively based on exposure history, signs, and public health context. (cdc.gov)

Why it matters: For veterinarians, this is less a practice-changing paper than a useful refinement of the exposure story. It supports continued client communication that pets in infected households may seroconvert without obvious active infection by the time they reach the clinic. It also underlines the value of careful history-taking, especially recent human illness in the home, when dogs and cats present with mild respiratory or GI signs. For disease surveillance teams, the more interesting signal is the possible interaction between pre-existing immunity and spillover response, which could shape future research on host susceptibility, assay interpretation, and surveillance design. (frontiersin.org)

What to watch: The next step is external validation. Researchers will need larger cohorts, variant-specific context, and prospective sampling closer to the time of household exposure to determine whether the antibody associations seen here are reproducible, biologically meaningful, or simply an artifact of a small, early-pandemic dataset. (frontiersin.org)